Duffy-null Associated Neutrphil Count (DANC) Pediatric Patients
NCT06547931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-03-27
Summary
There are currently no clinical and laboratory data that well characterize this neutropenia associated with the Duffy-null phenotype, particularly for pediatric subjects. In particular there are no data on the frequency of immune neutropenia in DANC neutropenic pediatric subjects.
The goal of this study is to :
* define the frequency of immune neutropenia within the cohort of DANC subjects under study
* evaluate the frequency of different degrees of neutropenia (mild-moderate-severe);
* evaluate the possible association between different degrees of neutropenia and the presence of infections.
Conditions
- Neutropenia Autoimmune
Interventions
- OTHER
-
Data collection and analysis
Retrospective collection of clinical and laboratory data relating to the definition of the nature of neutropenia
Sponsors & Collaborators
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
lead OTHER
Eligibility
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-30
- Primary Completion
- 2025-09-30
- Completion
- 2025-11-30
Countries
- Italy
Study Locations
More Related Trials
-
Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
NCT00239239 ·Status: COMPLETED ·Phase: PHASE2
-
Early Antibiotic Discontinuation in FUO
NCT02906254 ·Status: COMPLETED
-
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
NCT04662892 ·Status: UNKNOWN
-
Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy
NCT03434795 ·Status: COMPLETED
-
Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers
NCT00959777 ·Status: COMPLETED ·Phase: PHASE1
-
Pentaglobin in CRE and PA Neutropenic Infections
NCT03494959 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study
NCT03003273 ·Status: TERMINATED ·Phase: PHASE3
-
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
NCT02856204 ·Status: COMPLETED
-
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy
NCT00117624 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
NCT00111462 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy
NCT00110955 ·Status: COMPLETED ·Phase: PHASE3
-
Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
NCT05689450 ·Status: COMPLETED
-
Neutrophils in Bone Sarcomas
NCT04867421 ·Status: UNKNOWN
-
Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
NCT00945555 ·Status: COMPLETED
-
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
NCT02536599 ·Status: UNKNOWN
-
Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa
NCT00540696 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
NCT04910698 ·Status: COMPLETED
-
Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay
NCT02912117 ·Status: COMPLETED
-
Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer
NCT00091858 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy
NCT04547829 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
NCT00190463 ·Status: TERMINATED ·Phase: PHASE4
-
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
NCT03294577 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)
NCT03498248 ·Status: UNKNOWN ·Phase: NA
-
Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
NCT01450241 ·Status: WITHDRAWN ·Phase: NA